The hot startup has stopped collecting tiny vials of blood drawn from finger pricks for all but one of its tests, backing away from a method the company has touted as it rose to become one of Silicon Valley’s hottest startups.
from WSJ.com: US Business http://ift.tt/1GgZOEM
via IFTTT
No comments:
Post a Comment